Create 3D multiple myeloma model to aid preclinical development efforts

Multiple myeloma is an incurable cancer of the bone marrow; most patients develop resistance against first line therapy Velcade (bortezomib) sooner or later, which is a problem because few alternative drugs are available.

Part of the reason for this is that to date there have been no screening systems to allow scientists to study the effects of multiple myeloma drug candidates in a 3-D environment.

This may soon change according to European scientists who have grown miniature human myelomas in chicken eggs in a microenviroment that includes extracellular matrix compounds (ECM) and supportive stromal cells.

3D multiple myeloma model

3D Multiple Myeloma Model

“We wanted to generate a natural microenviroment by combining 3-D co-culture in ECM matrix with in vivo growth conditions in chicken embryos,” said Gerold Untergasser at Innsbruck Medical University in Austria.

“The previous standard 2 D culture was not very successful for testing drugs on myeloma cells, because some drugs were not very efficient in co-culture conditions, due to the supportive function of stromal cells.”

Trial assays have been successful according to Untergasser, who said novel marine compounds synthesized by Spanish API firm Pharmamar “displayed a strong anti-myeloma and anti-angiogenic activity,” Untergasser said.

Tumours in eggs

The scientists approach is to cultivate tumour cells with human mensenchymal cells from the bone marrow and collagen in the shape of 3-D cell spheres, simulating tumours in bone marrow.

After removing the eggshells, the researchers transfer the cell spheres to the outer chorioallantoic membrane. This membrane provides a perfect base for growing miniature human tumours in a petri dish. It allows putative drugs to be added to see if they can kill myeloma cells.

This is not straightforward because the mensenchymal cells protect the tumor in the test system just as they do in patients. Cancer drugs have to overcome this protective shield.

“We tested already tested four different human myeloma clones and work on refining of the system by including bone-replacement material based on hydroxyapatite (calcium apatite) to provide an optimal substrate for myeloma cell growth of bone marrow aspirates of patients,” Untergasser explained.

The spheroids have a diameter of about 2 mm and their generation takes just 1 to 2 hrs. The preparation of eggs takes about one week before grafting of spheroids.

The group is working to improve the system for patients by constructing spheroids that more resemble the natural microenviroment of the human bone.

Asked what benefits this technique offers, Untergasser said it makes large-scale screening of compounds more feasible, offers easy handling and imaging of tumours and is less costly than immunocompromised mice that require special facilities.

Also the embryonic tissue of the chorioallantoic membrane of chicken is a perfect substrate for growth of myeloma cells, because is strongly vascularized and full of supportive growth factors.

The technique was developed as part of an EU project called OPTATIO and a video publication was released in the Journal of Visualized Experiments. The video is entitled “Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis.”

Preclinical and clinical stages of drug development

Medicilon hosted a Preclinical Development of Innovative Drugs Summit

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration. The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies, ADCs , mRNA vaccines , small nucleic acid drugs , PROTAC , and CGT technical service platform that have helped 421 INDs obtain clinical approval. It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

阅读全文

What is Toxicokinetics?

Toxicokinetics is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms toxicokinetics , pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...

阅读全文

Shanghai Medicilon Inc.

搜索此博客